MTOR and cancer: Available evidence also suggests that miR‐100 is down‐regulated in many human cancers including breast, bladder and lung, by regulating proliferation, differentiation, migration, invasion, and apoptosis due to targeting the mTOR pathway (Li et al., 2015).